4HOLClK M, GIBSON H, KORNELUK R G. XIAP: apoptotic brake and promising therapeutic target [J]. Apoptosis , 2001,6(4) :2S3-261.
5ZOU T, RAO J N, GUO X, et al. NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion [J]. American Journal of Physiology-cell Physiology, 2004,286(S) :1009-1018.
6YANG Q H, DU C. Smac/DIABLO selectively reduces the levels of c- lAP1 and c- lAP2 but not that of XlAP and livin in HeLa cells[]J. The Journal of Biological Chemistry, 2004,279 (17):16963-16970.
7TAMM I, KORNBLAU S M, SEGALL H, et al. Expression and prognostic significance of lAP-family genes in human cancers and myeloid leukemias [J]. Clinical Cancer Research, 2000,6(S):1796-1803.
8CARTER B Z, MlLELLA M, TSAO T, et al. Regulation and targeting of antiapoptotic XlAP in acute myeloid leukemia[]J. Leukemia, 2003,17(1) :2081-2089.
9LI C Q, TRUDEL L J, WOGAN G N. Nitric oxide-induced genotoxicity , mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53 [J]. Proceedings of the National Academy of Sciences of the United States of America, 2002,99(6) :10364-10369.
10NIKOLOVSKA-COLESKA Z, XU L, HU Z, et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XlAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database[J]. Journal of Medicinal Chemistry, 2004,47 (10): 2430-2440.
